Arrhythmia Case Studies Content Courtesy of: John P. DiMarco, MD, PhD N.A. Mark Estes III, MD.

Slides:



Advertisements
Similar presentations
EP Testing and Use of Devices in Heart Failure HFSA 2010 Recommendations.
Advertisements

Bronze Level Electrocardiography
SMASH-VT Trial Presented at The Heart Rhythm Society Meeting May 2006 Presented by Dr. Vivek Reddy Substrate Mapping and Ablation in Sinus Rhythm to Halt.
By Dr.Ahmed Mostafa Assist. Prof. of anesthesia & I.C.U.
Brugada’s Syndrome and Sudden Cardiac Death
Ventricular Tachycardia
The Very Basics of Pacing Glenn Estell Medtronic Pribcipal Clinical Specialist.
TWA Testing in the EP Lab u To guide performance of EP study u To guide interpretation of EP study u To provide independent information along with the.
Thursday 4/12/2014 Hassan Alahmadi Medical Resident ( R1)
Telemetry Quiz February 11th, 2012 Dr. Irving Tiong Dr. Darren Kagal
Ventricular Arrhythmias
Telemetry/ACLS review
Heart Arrhythmia's Brandy Parker Brianne Negen Jeremy Grimm
Indications of ICD in 2010 Dr Mervat Aboulmaaty Professor of Cardiology Ain Shams University DAF 1 st EP course 2010.
Juan Camilo Diaz Cardiac Pacemakers.
Ventricular Tachyarrhythmias
Arrhythmia recognition and treatment
CARDIAC ARRHYTHMIA Charn Sriratanasathavorn, MD,FACC
Electrocardiogram Primer (EKG-ECG)
Fast & Easy ECGs, 2nd E – A Self-Paced Learning Program
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
Mr. J is a 70 year old man with an ischemic cardiomyopathy who presents with class III CHF and significant dissatisfaction with his functional capacity.
Chapter 17 Interpreting the Electrocardiogram
Pacemakers and Implantable Cardioverter Defibrillators Chapter 10
Atrial Fibrillation Andreas Stein Robert Smith, M.D. August 11, 2003.
Noninvasive evaluation of patients who are at risk for sudden cardiac death DR.A.YAMINISHARIF Tehran Heart Center.
Sudden Cardiac Death; Invasive Evaluation Alpay Çeliker MD Hacettepe University Department of Pediatric Cardiology Ankara, Türkiye.
Ventriclar Tachycardia
September 23, 2010 Morning Report. ECG Rate Rhythm What do you think? What do you want to do?
Fast & Easy ECGs – A Self-Paced Learning Program
Workshop #5 VT and ICD Unknowns Chair: David J. Wilber, MD Faculty: John P. DiMarco, MD, PhD Francis E. Marchlinski, MD.
AV Blocks Artificial Pacemakers Terry White, RN, EMT-P.
Pacemakers.
Device and Antiarrhythmic Drugs: Advantages and Pitfalls Teresa Menendez Hood, M.D.
ECG in Pacemaker Malfunction
Fast & Easy ECGs – A Self-Paced Learning Program
Introduction Most patients undergoing left ventricular assist device (LVAD) implantation for destination therapy (DT) also have an implantable cardioverter.
INTRODUCTION: INTRODUCTION: implantable cardioverter-defibrillators (ICDs) have clearly demonstrated to terminate an elevated percentage of sustained ventricular.
EP show – June 2004 EP show The EP show: Risk stratification for sudden death Eric Prystowsky MD Director, Clinical Electrophysiology Laboratory St Vincent.
Arrhythmias.
Slide Number1 Obtaining an ECG Recording the ECG (see Procedure 48-1) Standardization, sensitivity, and speed Mounting an ECG tracing.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 33 Disorders of Cardiac Conduction and Rhythm.
IN THE NAME OFGODIN THE NAME OFGOD SVTS.SAYAH.  All cardiac tachyarrhythmias are produced by: 1/disorders of impulse initiation :automatic 2/abnormalities.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Safety and efficacy of advanced atrial pacing therapies.
THE HEART’S ELECTRICAL SYSTEM Marco Perez, MD Center for Inherited Cardiovascular Disease Inherited Cardiac Arrhythmia Clinic June 20, 2013.
22nd April 2009 ECG Recording and Basic Interpretation.
Basics of Pacemaker Functioning
Lesson 11.2 Regulation of the Heart Chapter 11: The Cardiovascular System.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 25 Disorders of Cardiac Conduction and Rhythm.
Sudden Cardiac Arrest Morhaf Ibrahim, MD, FHRS Electrophysiology.
Objective 12 Electrocardiograms
American College of Cardiology Presented by Dr. Stuart J. Connolly
The Automated Implantable Cardiac Defibrillator
From: Pacemaker Malfunction
Pacemakers and Implantable Cardioverter-Defibrillators
ECG Advanced Basics for Interns - Arrhythmias
Arrhythmia Arrhythmia.
Pacemakers.
Dysrhythmias Disorders of formation or conduction (or both) of electrical impulses within heart Can cause disturbances of Rate Rhythm Both rate, rhythm.
Pacemakers and Devices – Interactive Session
Clinical Intracardiac Electrophysiologic Testing: Technique, Diagnostic Indications, and Therapeutic Uses  STEPHEN C. HAMMILL, M.D.  Mayo Clinic Proceedings 
Interventional cardiologist & internist
Electrocardiography for Healthcare Professionals
Challenges in the diagnosis and management of idiopathic ventricular fibrillation  Jonathan Lipton, MD, PhD, George J. Klein, MD, Raymond W. Sy, MBBS,
Ben Ng, MBBS, Robert W. Giles, MBBS, Zal Dastur, BSc, Mark A
Expanding the electrical phenotype of NKX2-5 mutations: Ventricular tachycardia, atrial fibrillation, and complete heart block within one family  Simone.
Volume 9, Issue 1, Pages (January 2012)
Haseeb Jafri, MD, Alan Cheng, MD, FHRS  HeartRhythm Case Reports 
Nothing inside the heart – Combining epicardial pacing with the S-ICD
An unusual ICD shock: What is the mechanism?
Presentation transcript:

Arrhythmia Case Studies Content Courtesy of: John P. DiMarco, MD, PhD N.A. Mark Estes III, MD

History A 62 year old male with a prior MI, ejection fraction of 25% and prior CABG had had a dual chamber defibrillator placed for inducible sustained monomorphic ventricular tachycardia after repetitive nonsustained episodes of VT were discovered on Holter monitor. At electrophysiology study he had inducible sustained VT with a cycle length of 340 msec Presentation He returns for routine follow up and after receiving an ICD shock and the following tracing is recorded. The following tracings represent sequential stored electrograms during a single tachycardia episode. Device Settings The device has been configured to a VT zone of 165 to 210 bpm with two bursts of ATP followed by low energy conversion shock at 1.1 joule. VF zone was configured with 33 joule shock for rates greater than 210 bpm. Rate sensing atrial and ventricular electrograms are shown with the shock electrograms recorded from the shock coil. CASE #1

Case study 1- Question 1 The tracing above shows which of the following: A. Ventricular tachycardia with AV dissociation with appropriate ATP B. Ventricular tachycardia with 1:1 VA conduction with appropriate ATP C. Sinus tachycardia D. Atrial fibrillation with a rapid ventricular response

Case #1- Question 1 Answer The tracing above shows which of the following: A. Ventricular tachycardia with AV dissociation with appropriate ATP B. Ventricular tachycardia with 1:1 VA conduction with appropriate ATP C. Sinus tachycardia D. Atrial fibrillation with a rapid ventricular response The tracing shows sinus tachycardia with two atrial premature contractions prior to the 2 bursts of antitachycardia pacing. Ventricular tachycardia with AV dissociation is excluded by the 1:1 AV relationship. Ventricular tachycardia with 1:1 conduction is excluded by the change in A-A intervals preceding the change in V-V intervals. Atrial fibrillation is excluded by the discrete atrial electrograms with cycle lengths of approximately 360 msec. The atrial and ventricular electrograms in tracing 1A are morphologically identical to those in1C after shock therapy. The rate of the sinus tachycardia exceeds the rate cut off with a ventricular tachycardia zone of 165 bpm.

Case 1- Question 2 The tracing above shows which of the following: A. Ventricular tachycardia shocked to ventricular fibrillation B. Ventricular tachycardia shocked to atrial fibrillation C. Sinus tachycardia shocked to atrial fibrillation D. Sinus tachycardia shocked to NSR

Case #1- Question 2 Answer The tracing above shows which of the following: A. Ventricular tachycardia shocked to ventricular fibrillation B. Ventricular tachycardia shocked to atrial fibrillation C. Sinus tachycardia shocked to atrial fibrillation D. Sinus tachycardia shocked to NSR In the tracing, sinus tachycardia persists at greater than 165 bpm and a 1.1 joule shock indicated by the arrow induces atrial fibrillation. The post shock ventricular electrograms are similar to those before the shock with one paced beat (VP). The irregular rapid atrial electrograms indicate atrial fibrillation is present and the marker channel indicates appropriate atrial sensing. Because the atrial fibrillation results in a ventricular response at rates greater than 165 beats/minute it is detected as ventricular tachycardia with average rate of 177 bpm.

Case 1- Question 3 The tracing above shows which of the following: A. Ventricular fibrillation shocked to sinus rhythm B. Ventricular tachycardia shocked to normal sinus rhythm C. Atrial fibrillation shocked to ventricular tachycardia D. Atrial fibrillation shocked to sinus rhythm

Case #1- Question 3 Answer The tracing above shows which of the following: A. Ventricular fibrillation shocked to sinus rhythm B. Ventricular tachycardia shocked to normal sinus rhythm C. Atrial fibrillation shocked to ventricular tachycardia D. Atrial fibrillation shocked to sinus rhythm The tracing shows atrial fibrillation with a rapid ventricular response of approximately 190 bpm is present. The device subsequently delivers a 33 joule shock re-establishing sinus rhythm after multiple premature ventricular contractions. The shock electrogram widening is commonly seen immediately after shocks from polarization artifact and typically returns to normal within several seconds.

A. Start amiodarone B. Institute beta blocker therapy to prevent sinus tachycardia C. Program stability criteria to prevent therapy for atrial fibrillation D. Increase the rate cut off for detection in the VT zone to 190 bpm E. A and C The most appropriate therapy based on the available clinical information above would be which of the following: Case #1 – Question 4

Case #1 – Question 4 Answer A. Start amiodarone B. Institute beta blocker therapy to prevent sinus tachycardia C. Program stability criteria to prevent therapy for atrial fibrillation D. Increase the rate cut off for detection in the VT zone to 190 bpm E. A and C The most appropriate therapy based on the available clinical information above would be which of the following:

History A 62 year old male with a prior MI, ejection fraction of 25% and prior CABG had had a dual chamber defibrillator placed for inducible sustained monomorphic ventricular tachycardia after repetitive nonsustained episodes of VT were discovered on Holter monitor. At electrophysiology study he had inducible sustained VT with a cycle length of 340 msec. Device Settings VT zone of 165 to 210 bpm with two bursts of ATP followed by low energy conversion shock at 1.1 joule. VF zone was configured with 33 joule shock for rates greater than 210 bpm. Presentation He returns for routine follow up and after receiving an ICD shock and the following tracing is recorded. Rate sensing atrial and ventricular electrograms are shown with the shock electrograms recorded from the shock coil. CASE #2

Initial rhythm in this tracing shows which of the following: A.Ventricular tachycardia with AV dissociation with appropriate ATP B.Ventricular tachycardia with 1:1 VA conduction with appropriate ATP C.Sinus tachycardia D.Atrial fibrillation with a rapid ventricular response Case #2- Question 1

Initial rhythm in this tracing shows which of the following: A. Ventricular tachycardia with AV dissociation with appropriate ATP B. Ventricular tachycardia with 1:1 VA conduction with appropriate ATP C. Sinus tachycardia D. Atrial fibrillation with a rapid ventricular response Case #2- Question 1 Answer

The tracing below shows which of the following: A.Ventricular tachycardia shocked to ventricular fibrillation B.Ventricular tachycardia shocked to atrial fibrillation C.Sinus tachycardia shocked to atrial fibrillation D.Sinus tachycardia shocked to NSR Case #2- Question 2

The tracing below shows which of the following: A. Ventricular tachycardia shocked to ventricular fibrillation B. Ventricular tachycardia shocked to atrial fibrillation C. Sinus tachycardia shocked to atrial fibrillation D. Sinus tachycardia shocked to NSR Case #2- Question 2 Answer

The tracing below shows which of the following: A.Ventricular fibrillation shocked to sinus rhythm B.Ventricular tachycardia shocked to normal sinus rhythm C.Atrial fibrillation shocked to ventricular tachycardia D.Atrial fibrillation shocked to sinus rhythm Case #2- Question 3

Case #2- Question 3 Answer The tracing below shows which of the following: A.Ventricular fibrillation shocked to sinus rhythm B.Ventricular tachycardia shocked to normal sinus rhythm C.Atrial fibrillation shocked to ventricular tachycardia D.Atrial fibrillation shocked to sinus rhythm

The most appropriate therapy based on the available clinical information above would be which of the following: A.Start amiodarone B.Institute beta blocker therapy to prevent sinus tachycardia C.Program stability criteria to prevent therapy for atrial fibrillation D.Increase the rate cut off for detection in the VT zone to 190 bpm E.A and C Case #2- Question 4

The most appropriate therapy based on the available clinical information above would be which of the following: A.Start amiodarone B.Institute beta blocker therapy to prevent sinus tachycardia C.Program stability criteria to prevent therapy for atrial fibrillation D.Increase the rate cut off for detection in the VT zone to 190 bpm E.A and C Case #2- Question 4 Answer

CASE #3 History A 65-year-old male had prior 3 vessel disease and CABG with congestive heart failure and ejection fraction of 15%. He had documented sustained ventricular tachycardia with syncope and based on this a dual chamber ICD was placed. Device Settings VT Zone with anti-tachycardia pacing (ATP) for rate of 130 to 200 bpm followed by low energy cardioversion. For rates greater than 200 bpm maximum shock was programmed. Presentation The tracing represents the stored electrograms. The electrograms are shown from the right atrial and ventricular leads and the shock coil.

The tracing shows which of the following: A.Atrial fibrillation with a rapid ventricular response B.Sinus tachycardia C.Ventricular tachycardia with atrioventricular dissociation D.Ventricular tachycardia with VA association Case #3- Question 1

Case #3- Question 1 Answer The tracing shows which of the following: A.Atrial fibrillation with a rapid ventricular response B.Sinus tachycardia C.Ventricular tachycardia with atrioventricular dissociation D.Ventricular tachycardia with VA association

Which of the following is true for the beats labeled 2 and 3 after antitachycardia pacing: A.Normal sinus rhythm results with conduction through the AV node B.Ventricular tachycardia persists but at a lower rate C.Ventricular tachycardia is terminated and the patient shows PV pacing D.Atrial fibrillation is present Case #3- Question 2

Which of the following is true for the beats labeled 2 and 3 after antitachycardia pacing: A.Normal sinus rhythm results with conduction through the AV node B.Ventricular tachycardia persists but at a lower rate C.Ventricular tachycardia is terminated and the patient shows PV pacing D.Atrial fibrillation is present Case #3- Question 2 Answer

CASE #4 History A 55 year old women with a history of prior myocardial infarction and ejection fraction of 20% and known anterior apical aneurysm had previously had a dual chamber pacemaker laced with bipolar leads because of sinus bradycardia. She subsequently developed sustained monomorphic ventricular tachycardia which was inducible in the EP Lab and treated with a single chamber ICD. At the time of implantation, interaction testing between the pacemaker and ICD indicated clinically significant interaction. However, at routine follow up the patient 20 months later, it was noticed that there was sensing of the pacemaker stimulus outputs by the ICD. The capture threshold for the ventricular pacemaker was 3.0 volts at 0.6 msec and the output had been programmed to 5.0 volts at 0.6 msec. The tracing shown represents interaction testing which was done at that time.

Ventricular fibrillation was induced with shock on T. Which of the following statements is true regarding the subsequent arrhythmia? A.There is oversensing of the atrial stimulus output by the ICD B.There is oversensing of the ventricular stimulus output by the ICD C.There is undersensing of the ventricular fibrillation D.All of the above are true 4-1 Case #4- Question 1

Ventricular fibrillation was induced with shock on T. Which of the following statements is true regarding the subsequent arrhythmia? A.There is oversensing of the atrial stimulus output by the ICD B.There is oversensing of the ventricular stimulus output by the ICD C.There is undersensing of the ventricular fibrillation D.All of the above are true Case #4- Question 1 Answer

The most appropriate response to this would be which of the following? A.Make the ICD ventricular sensitivity less sensitive B.Decrease the output of the ventricular pacemaker to 2.5 volts and re-test for interaction C.Place a new rate sensing lead for the ICD D.Place a dual chamber ICD and remove the pacemaker Case #4- Question 2

The most appropriate response to this would be which of the following? A.Make the ICD ventricular sensitivity less sensitive B.Decrease the output of the ventricular pacemaker to 2.5 volts and re-test for interaction C.Place a new rate sensing lead for the ICD D.Place a dual chamber ICD and remove the pacemaker Case #4- Question 2 Answer

40 year old man with single episode of dizziness. 12 lead ECG at time of evaluation CASE #5

CASE #5- Question 1 Which of the following is not true related to the patient’s arrhythmia syndrome? A.The patient arrhythmias will be effectively suppressed with beta blockers. B.The arrhythmia syndrome has been linked to a mutation in the cardiac potassium channel gene SCN5A located on chromosome 3 C.The ECG abnormality can usually be provoked or potentiated by quinidine. D.All of the above

Which of the following is not true related to the patient’s arrhythmia syndrome? A.The patient arrhythmias will be effectively suppressed with beta blockers. B.The arrhythmia syndrome has been linked to a mutation in the cardiac potassium channel gene SCN5A located on chromosome 3 C.The ECG abnormality can usually be provoked or potentiated by quinidine. D.All of the above Case #5- Question 1 Answer

Which of the following has been reported as being associated with the patient’s arrhythmia syndrome? A.Mutations on chromosome 3 have been described for both LQT3 and the patient’s syndrome B.The syndrome typically presents as rapid uniform sustained VT C.The syndrome is most common in European males D.The relative prominent transient outward current and resultant transmural inhomogeneity in ventricular repolarization associated with this syndrome is primarily confined to the LV epicardium Case #5- Question 2

Which of the following has been reported as being associated with the patient’s arrhythmia syndrome? A.Mutations on chromosome 3 have been described for both LQT3 and the patient’s syndrome B.The syndrome typically presents as rapid uniform sustained VT C.The syndrome is most common in European males D.The relative prominent transient outward current and resultant transmural inhomogeneity in ventricular repolarization associated with this syndrome is primarily confined to the LV epicardium Case #5- Question 2 Answer

Case 5- Question 3 Which of the following is true concerning catheter ablation in this patient? A.The risk of catheter ablation and cardiac perforation exceeds 20 % and should not be attempted B.The patients VT is likely to originate from the mid RV free wall C.Pacemapping alone is typically used to map VT in this setting D.None of the above

Which of the following is true concerning catheter ablation in this patient? Case 5- Question 3 Answer A.The risk of catheter ablation and cardiac perforation exceeds 20 % and should not be attempted B.The patients VT is likely to originate from the mid RV free wall C.Pacemapping alone is typically used to map VT in this setting D.None of the above

CASE #6- Question 1 A 30 year old Spanish man is referred because of syncope and an abnormal ECG as shown. His younger brother who is symptom free accompanies him and has a normal ECG.

CASE #6

Case 6: Question 1 Administration of which of the following drugs would be helpful in the brother’s evaluation? A.Sotalol B.Isoproterenol C.Flecainide D.Adenosine E.Verapamil

Administration of which of the following drugs would be helpful in the brother’s evaluation? A.Sotalol B.Isoproterenol C.Flecainide D.Adenosine E.Verapamil Case #6- Question 1 Answer